Abstract
Treatment of rheumatoid arthritis with glucocorticoids remains controversial despite a considerable and growing body of evidence. This chapter focuses on the research agenda in urgent need of execution: to define conclusively the benefit/harm trade-offs and pin down the place of these agents in the treatment cascade.
MeSH terms
-
Arthritis, Rheumatoid / diagnosis
-
Arthritis, Rheumatoid / drug therapy*
-
Clinical Trials as Topic
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Forecasting
-
Glucocorticoids / adverse effects*
-
Glucocorticoids / therapeutic use*
-
Humans
-
Male
-
Netherlands
-
Research Design*
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome